Xeomin 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FY8RP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,352
Award facts
- Contract value 100% obligated
- $3,352.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for 100-unit vials of Xeomin, a botulinum toxin product used for medical purposes, valued at $3,352.44. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 21, 2025. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary headquarters. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and critical vendor for federal medical procurement, supplies pharmaceutical products and medical devices to support military and veteran healthcare systems. The parent SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to furnish a broad range of medications, vaccines, specialty drugs, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations worldwide. This delivery order for Xeomin exemplifies the type of specialized pharmaceutical products procured through AmerisourceBergen's established federal contract relationships to support defense and military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FY8RP?
SPE2DB25FY8RP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FY8RP worth?
The government has obligated $3,352 on SPE2DB25FY8RP.
Is contract SPE2DB25FY8RP an order under another contract?
Yes. SPE2DB25FY8RP is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FY8RP competed?
The extent of competition for SPE2DB25FY8RP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award